BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Satarker S, Bojja SL, Gurram PC, Mudgal J, Arora D, Nampoothiri M. Astrocytic Glutamatergic Transmission and Its Implications in Neurodegenerative Disorders. Cells 2022;11:1139. [PMID: 35406702 DOI: 10.3390/cells11071139] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Palabas T, Torres JJ, Perc M, Uzuntarla M. Double stochastic resonance in neuronal dynamics due to astrocytes. Chaos, Solitons & Fractals 2023;168:113140. [DOI: 10.1016/j.chaos.2023.113140] [Reference Citation Analysis]
2 Gabryelska A, Turkiewicz S, Ditmer M, Sochal M. Neurotrophins in the Neuropathophysiology, Course, and Complications of Obstructive Sleep Apnea—A Narrative Review. IJMS 2023;24:1808. [DOI: 10.3390/ijms24031808] [Reference Citation Analysis]
3 Schwarz K, Schmitz F. Synapse Dysfunctions in Multiple Sclerosis. Int J Mol Sci 2023;24. [PMID: 36675155 DOI: 10.3390/ijms24021639] [Reference Citation Analysis]
4 Chakraborty P, Dey A, Gopalakrishnan AV, Swati K, Ojha S, Prakash A, Kumar D, Ambasta RK, Jha NK, Jha SK, Dewanjee S. Glutamatergic neurotransmission: A potential pharmacotherapeutic target for the treatment of cognitive disorders. Ageing Res Rev 2023;85:101838. [PMID: 36610558 DOI: 10.1016/j.arr.2022.101838] [Reference Citation Analysis]
5 Nampoothiri M, Kolathur KK, Sankhe R, Satarker S. Spermidine, an Autophagy Inducer, as a Therapeutic Antiaging Strategy. Emerging Anti-Aging Strategies 2023. [DOI: 10.1007/978-981-19-7443-4_8] [Reference Citation Analysis]
6 Nassar A, Kodi T, Satarker S, Chowdari Gurram P, Upadhya D, Sm F, Mudgal J, Nampoothiri M. Astrocytic MicroRNAs and Transcription Factors in Alzheimer's Disease and Therapeutic Interventions. Cells 2022;11. [PMID: 36552875 DOI: 10.3390/cells11244111] [Reference Citation Analysis]
7 Gurram PC, Satarker S, Nassar A, Mudgal J, Nampoothiri M. Virtual structure-based docking and molecular dynamics of FDA-approved drugs for the identification of potential IKKB inhibitors possessing dopaminergic activity in Alzheimer’s disease. Chem Pap 2022. [DOI: 10.1007/s11696-022-02598-y] [Reference Citation Analysis]
8 Samojedny S, Czechowska E, Pańczyszyn-trzewik P, Sowa-kućma M. Postsynaptic Proteins at Excitatory Synapses in the Brain—Relationship with Depressive Disorders. IJMS 2022;23:11423. [DOI: 10.3390/ijms231911423] [Reference Citation Analysis]
9 Pan S, Lv Z, Wang R, Shu H, Yuan S, Yu Y, Shang Y, Rai SN. Sepsis-Induced Brain Dysfunction: Pathogenesis, Diagnosis, and Treatment. Oxidative Medicine and Cellular Longevity 2022;2022:1-13. [DOI: 10.1155/2022/1328729] [Reference Citation Analysis]
10 Teleanu RI, Niculescu AG, Roza E, Vladâcenco O, Grumezescu AM, Teleanu DM. Neurotransmitters-Key Factors in Neurological and Neurodegenerative Disorders of the Central Nervous System. Int J Mol Sci 2022;23:5954. [PMID: 35682631 DOI: 10.3390/ijms23115954] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]